ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis: Report of three cases and review of the literature

American Journal of Clinical Pathology

Volumn 120, Issue 4, 2003, Pages 617-625

  Onciu, Mihaela ^a   Behm, Frederick G ^a,b   Raimondi, Susana C ^a,b   Moore, Sheila ^c   Harwood, Emma L ^d   Pui, Ching Hon ^a,b   Sandlund, John T ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c OUR LADY OF THE LAKE REGIONAL MEDICAL CENTER   (United States)

^d St Luke's Mountain States Tumor Institute   (United States)

Author keywords

ALK; Anaplastic lymphoma; Anaplastic lymphoma kinase; Blood; Leukemia; Non Hodgkin lymphoma

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD11B ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; PREDNISONE; VINCRISTINE;

ANAPLASTIC LARGE CELL LYMPHOMA; ANTIGEN EXPRESSION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOSPLENOMEGALY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INFANT; LARGE CELL LYMPHOMA; LUNG INFILTRATE; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RESPIRATORY DISTRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; FATAL OUTCOME; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; LEUKEMIA; LYMPHOMA, LARGE-CELL, KI-1; MALE; NEOPLASMS, MULTIPLE PRIMARY; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 0141432234     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/WH8PNU9PK4RRV852     Document Type: Review

References (33)

1. Delsol G, Ralfkier E, Stein H, et al. Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lmphoid Tissues. Lyon, France: IARC Press; 2001:230-235. World Health Organization Classification of Tumours.
2. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical use. Cancer. 1982;49:2112-2135.
3. Stein H, Foss H-D, Dürkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic and clinical features. Blood. 2000;96:3681-3695.
4. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood. 1998;91:2076-2084.
5. Falini B, Bigerna B, Fizzotti M, et al. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol. 1998;153:875-885.
6. Chott A, Kaserer K, Augustin I, et al. Ki-1 positive anaplastic large cell lymphoma: a clinicopathologic study of 41 cases. Am J Surg Pathol. 1990;14:439-448.
7. Kinney MC, Collins RD, Greer JP, et al. A small-cell-predominant variant of primary Ki-1 (CD30) + T-cell lymphoma. Am J Surg Pathol. 1993;17:859-868.
8. Ott G, Bastian BC, Katzenberger T, et al. A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation. Br J Haematol. 1998;100:187-190.
9. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994;263:1281-1284.
10. Morris SW, Naeve C, Mathew P, et al. ALK, the chromosome 2 gene locus altered by the t(2;5) translocation in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene. 1997;14:2175-2188.
11. Mathew P, Sanger WG, Weisenburger DD, et al. Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization. Blood. 1997;89:1678-1685.
12. Downing JR, Shurtleff SA, Zielenska M, et al. Molecular detection of the t(2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood. 1995;85:3416-3422.
13. Greer JP, Kinney MC, Colllins RD, et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol. 1991;9:539-547.
14. Gordon BG, Weisenburger DD, Warkentin PI, et al. Peripheral T-cell lymphoma in childhood and adolescence. Cancer. 1993;71:257-263.
15. Harris NL. Mature B-cell neoplasms: Introduction. In: Jaffe ES, Harris NL, Stein H, et al, editors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:121-126. World Health Organization Classification of Tumours.
16. Bosch F, López-Guillermo A, Campo E, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer. 1998;82;567-575.
17. Kim YH, Hoppe RT. Mycosis fungoides and the Sézary syndrome. Semin Oncol. 1999;26:276-289.
18. Shimoyama M. Diagnostic criteria and subclassification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991;79:428-437.
19. Anderson MM, Ross CW, Singleton TP, et al. Ki-1 anaplastic large cell lymphoma with a prominent leukemic phase. Hum Pathol. 1996;27:1093-1095.
20. Villamor N, Rozman M, Esteve J, et al. Anaplastic large-cell lymphoma with rapid evolution to leukemic phase. Ann Hematol. 1999;78:478-482.
21. Bayle C, Charpentier A, Duchayne E, et al. Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases. Br J Haematol. 1999;104:680-688.
22. Meech SJ, McGavran L, Odom LF, et al. Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4-anaplastic lymphoma kinase gene fusion. Blood. 2001;98:1209-1216.
23. Awaya N, Mori S, Takeuchi H, et al. CD30 and NPM-ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma. Am J Hematol. 2002;69:200-204.
24. Chhanabhai M, Britten C, Klasa R, et al. t(2;5) positive lymphoma with peripheral blood involvement. Leuk Lymphoma. 1997;28:415-422.
25. Wong KF, Chan JKC, Ng CS, et al. Anaplastic large cell Ki-1 lymphoma involving bone marrow: marrow findings and association with reactive hemophagocytosis. Am J Hematol. 1991;37:112-119.
26. Raimondi SC, Mathew S, Pui CH. Cytogenetics as a diagnostic aid for childhood hematologic disorders: conventional cytogenetic techniques, fluorescence in situ hybridization, and comparative genomic hybridization. In: Hanausek M, Walaszek Z, eds. Tumor Marker Protocols. Totowa, NJ: Humana Press; 1998:209-227. Methods in Molecular Medicine; vol 14.
27. Mitelman F, ed. ISCN 1995: An International System for Human Cytogenetic Nomenclature (1995). Basel, Switzerland: S. Karger; 1995.
28. Stein H, Mason DY, Gerdes J, et al. The expression of Hodgkin's disease associated Ki-1 antigen in reactive and neoplastic lymphoid tissues: evidence that Sternberg-Reed cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66:848-858.
29. Delsol G, Lamant L, Mariamé B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood. 1997;89:1483-1490.
30. Pawson R, Matutes E, Brito-Babapulle V, et al. Sézary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia? Leukemia. 1997;11:1009-1013.
31. Juco J, Holden JT, Mann KP, et al. Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry. Am J Clin Pathol. 2003;119:205-212.
32. Paranjape GS, Asplund SL, Jamal S, et al. Anaplastic large cell lymphoma: a flow cytometric analysis of 18 cases. Presented at the 2002 Annual Meeting of the United States and Canadian Academy of Pathology; February 23-March 1, 2002; Chicago, IL. Abstract 1072.
33. Popnikolov NK, Payne DA, Hudnall SD, et al. CD13-positive anaplastic large cell lymphoma of T-cell origin: a diagnostic and histogenetic problem. Arch Pathol Lab Med. 2000;124:1804-1808.